Alivus Life Sciences Ltd.

The revenue zoomed 5.93% to Rs. 5728.04 millions for the quarter ended December 2023 as compared to Rs. 5407.31 millions during the corresponding quarter last year.Net profit stood at Rs. 1187.65  millions  compared to Rs. 1049.93 millions in the corresponding previous quarter,high by 13.12%.The company reported a good operating profit of 1742.47 millions compared to 1520.64 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202312	202212	% Var	202312	202212	% Var	202303	202203	% Var
Sales	5728.04	5407.31	5.93	17466.17	15399.00	13.42	21612.20	21232.14	1.79
Other Income	16.91	66.08	-74.41	89.11	261.21	-65.89	289.57	147.04	96.93
PBIDT	1742.47	1520.64	14.59	5417.12	4619.84	17.26	6712.50	6307.64	6.42
Interest	3.87	1.60	141.87	11.82	4.28	176.17	5.47	279.62	-98.04
PBDT	1738.60	1519.04	14.45	5405.30	4615.56	17.11	6707.03	6028.02	11.26
Depreciation	131.77	107.63	22.43	389.18	305.77	27.28	420.94	378.77	11.13
PBT	1606.83	1411.41	13.85	5016.12	4309.79	16.39	6286.09	5649.25	11.27
TAX	419.18	361.48	15.96	1286.60	1103.75	16.57	1616.48	1462.01	10.57
Deferred Tax	30.57	29.70	2.93	75.00	70.75	6.01	110.37	85.74	28.73
PAT	1187.65	1049.93	13.12	3729.52	3206.04	16.33	4669.61	4187.24	11.52
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	30.42	28.12	8.17	31.01	30.00	3.38	31.06	29.71	4.55